All In MedTech

FDA Clearance Tracker · P030031-S135

nMARQ Catheter Interference Cable

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 15, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 15, 2024

Approved

Time to decision

248 days

Received Mar 12, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030031-S135
Device name
nMARQ Catheter Interference Cable
Applicant location
Irvine, CA
Received
Mar 12, 2024
Decided
Nov 15, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P030031

Device type

Device class
Class III

Every decision under product code OAD

FDA's approval statement

As written in FDA's record.

an alternate manufacturing site located in Tijuana, Baja California, Mexico (Establishment Registration Number 3008093809) for the TX eco EXT Cable, nMARQ Catheter Interface Cable, and the SmartAblate System Interface Cable

Source documents

Other decisions for Biosense Webster, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.